Based on previous basic experiments revealing that patients with type 2 diabetic nephropathy exhibit higher blood lead levels than the general population, this study aims to systematically evaluate the impacts of short-term and long-term blood lead exposure on renal function progression in such patients, so as to provide novel epidemiological evidence for clinical intervention.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
42
Calcium Disodium Edetate Injection
Change in estimated glomerular filtration rate (eGFR) from baseline at 12 months follow-up after intravenous lead chelation therapy
Time frame: 3 months of intravenous lead chelation intervention, followed by 12 months of follow-up assessment with detections every 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.